Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 163

1.

RANTES production from CD4+ lymphocytes correlates with host genotype and rates of human immunodeficiency virus type 1 disease progression.

Paxton WA, Neumann AU, Kang S, Deutch L, Brown RC, Koup RA, Wolinsky SM.

J Infect Dis. 2001 Jun 1;183(11):1678-81. Epub 2001 Apr 25.

PMID:
11343219
[PubMed - indexed for MEDLINE]
Free Article
2.

CCR5 genotype and plasma beta-chemokine concentration of Brazilian HIV-infected individuals.

Mikawa AY, Tagliavini SA, Costa PI.

Braz J Med Biol Res. 2002 Nov;35(11):1333-7.

PMID:
12426633
[PubMed - indexed for MEDLINE]
Free Article
3.

CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection.

de Roda Husman AM, Blaak H, Brouwer M, Schuitemaker H.

J Immunol. 1999 Oct 15;163(8):4597-603.

PMID:
10510404
[PubMed - indexed for MEDLINE]
Free Article
4.

Changes in CCR5 and CXCR4 expression and beta-chemokine production in HIV-1-infected patients treated with highly active antiretroviral therapy.

Pierdominici M, Giovannetti A, Ensoli F, Mazzetta F, Marziali M, De Cristofaro MR, Santini-Muratori D, Leti W, Aiuti F.

J Acquir Immune Defic Syndr. 2002 Feb 1;29(2):122-31.

PMID:
11832680
[PubMed - indexed for MEDLINE]
5.

Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.

Cohen OJ, Vaccarezza M, Lam GK, Baird BF, Wildt K, Murphy PM, Zimmerman PA, Nutman TB, Fox CH, Hoover S, Adelsberger J, Baseler M, Arthos J, Davey RT Jr, Dewar RL, Metcalf J, Schwartzentruber DJ, Orenstein JM, Buchbinder S, Saah AJ, Detels R, Phair J, Rinaldo C, Margolick JB, Pantaleo G, Fauci AS.

J Clin Invest. 1997 Sep 15;100(6):1581-9.

PMID:
9294127
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Positive association between beta-chemokine-producing T cells and HIV type 1 viral load in HIV-infected subjects in Abidjan, Côte d'Ivoire.

Jennes W, Sawadogo S, Koblavi-Dème S, Vuylsteke B, Maurice C, Roels TH, Chorba T, Nkengasong JN, Kestens L.

AIDS Res Hum Retroviruses. 2002 Feb 10;18(3):171-7.

PMID:
11839151
[PubMed - indexed for MEDLINE]
7.

Effects of plasma HIV RNA, CD4+ T lymphocytes, and the chemokine receptors CCR5 and CCR2b on HIV disease progression in hemophiliacs. Hemophilia Growth and Development Study.

Daar ES, Lynn H, Donfield S, Gomperts E, Hilgartner MW, Hoots K, Chernoff D, Winkler C, O'Brien SJ.

J Acquir Immune Defic Syndr. 1999 Aug 1;21(4):317-25.

PMID:
10428111
[PubMed - indexed for MEDLINE]
8.

Circulating levels and ex vivo production of beta-chemokines, interferon gamma, and interleukin 2 in advanced human immunodeficiency virus type 1 infection: the effect of protease inhibitor therapy.

De Luca A, Giancola ML, Cingolani A, Ammassari A, Murri R, Antinori A.

AIDS Res Hum Retroviruses. 2000 Jun 10;16(9):835-43.

PMID:
10875609
[PubMed - indexed for MEDLINE]
9.

Chemokine pattern in relation to disease state in human immunodeficiency virus-infected children.

Than S, Tumaliuan JA, Tamma S, Morales M, Bakshi S, Pahwa S.

AIDS Res Hum Retroviruses. 1999 Sep 20;15(14):1279-85.

PMID:
10505676
[PubMed - indexed for MEDLINE]
10.

Impact of heterozygosity for the chemokine receptor CCR5 32-bp-deleted allele on plasma virus load and CD4 T lymphocytes in perinatally human immunodeficiency virus-infected children at 8 years of age.

Buseyne F, Janvier G, Teglas JP, Ivanoff S, Burgard M, Bui E, Mayaux MJ, Blanche S, Rouzioux C, Rivière Y.

J Infect Dis. 1998 Oct;178(4):1019-23.

PMID:
9806029
[PubMed - indexed for MEDLINE]
Free Article
11.

Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines.

Paxton WA, Liu R, Kang S, Wu L, Gingeras TR, Landau NR, Mackay CR, Koup RA.

Virology. 1998 Apr 25;244(1):66-73.

PMID:
9581779
[PubMed - indexed for MEDLINE]
Free Article
12.

CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression.

Reynes J, Portales P, Segondy M, Baillat V, André P, Avinens O, Picot MC, Clot J, Eliaou JF, Corbeau P.

AIDS. 2001 Sep 7;15(13):1627-34.

PMID:
11546936
[PubMed - indexed for MEDLINE]
13.

HIV-specific cellular immune response is inversely correlated with disease progression as defined by decline of CD4+ T cells in relation to HIV RNA load.

Oxenius A, Price DA, Hersberger M, Schlaepfer E, Weber R, Weber M, Kundig TM, Böni J, Joller H, Phillips RE, Flepp M, Opravil M, Speck RF; Swiss HIV Cohort Study.

J Infect Dis. 2004 Apr 1;189(7):1199-208. Epub 2004 Mar 17.

PMID:
15031788
[PubMed - indexed for MEDLINE]
Free Article
14.

Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression.

Liu H, Chao D, Nakayama EE, Taguchi H, Goto M, Xin X, Takamatsu JK, Saito H, Ishikawa Y, Akaza T, Juji T, Takebe Y, Ohishi T, Fukutake K, Maruyama Y, Yashiki S, Sonoda S, Nakamura T, Nagai Y, Iwamoto A, Shioda T.

Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4581-5.

PMID:
10200305
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission.

Hladik F, Liu H, Speelmon E, Livingston-Rosanoff D, Wilson S, Sakchalathorn P, Hwangbo Y, Greene B, Zhu T, McElrath MJ.

J Virol. 2005 Sep;79(18):11677-84.

PMID:
16140745
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Association between CCR5 genotype and the clinical course of HIV-1 infection.

de Roda Husman AM, Koot M, Cornelissen M, Keet IP, Brouwer M, Broersen SM, Bakker M, Roos MT, Prins M, de Wolf F, Coutinho RA, Miedema F, Goudsmit J, Schuitemaker H.

Ann Intern Med. 1997 Nov 15;127(10):882-90.

PMID:
9382366
[PubMed - indexed for MEDLINE]
17.

Statins disrupt CCR5 and RANTES expression levels in CD4(+) T lymphocytes in vitro and preferentially decrease infection of R5 versus X4 HIV-1.

Nabatov AA, Pollakis G, Linnemann T, Paxton WA, de Baar MP.

PLoS One. 2007 May 23;2(5):e470.

PMID:
17520029
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group.

Meyer L, Magierowska M, Hubert JB, Rouzioux C, Deveau C, Sanson F, Debre P, Delfraissy JF, Theodorou I.

AIDS. 1997 Sep;11(11):F73-8.

PMID:
9302436
[PubMed - indexed for MEDLINE]
19.

Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice.

Bahr GM, Darcissac EC, Castéran N, Amiel C, Cocude C, Truong MJ, Dewulf J, Capron A, Mouton Y.

J Virol. 2001 Aug;75(15):6941-52.

PMID:
11435574
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.

Losana G, Bovolenta C, Rigamonti L, Borghi I, Altare F, Jouanguy E, Forni G, Casanova JL, Sherry B, Mengozzi M, Trinchieri G, Poli G, Gerosa F, Novelli F.

J Leukoc Biol. 2002 Oct;72(4):735-42.

PMID:
12377943
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk